One night to walk 21km for cancer – 4 December | Last chance!

Free online training for prostate cancer care

Wednesday 24 July, 2019

Prostate cancer eLearning

With prostate cancer the second most common cancer diagnosed in men in Australia and the third most common cause of cancer death, it’s important to be across the latest cancer care pathways.

This evidence-based training course uses case studies to illustrate steps in prevention, early detection, initial investigation and referral pathways for prostate cancer patients.

At the completion of the course, you’ll be able to:

• Describe the current evidence related to prevention, early detection, presentation, initial investigation and referral for prostate cancer. 

• Use evidence-based tools and resources to determine patients' risk of prostate cancer and help asymptomatic patients decide whether to proceed with prostate-specific antigen (PSA) testing. 

• Identify how to access local diagnostic imaging and specialist appointment referral pathways for patients presenting with signs and symptoms of prostate cancer. 

The training module uses the Optimal Care Pathways series of resources, a national standard for high-quality cancer care, endorsed by Cancer Australia, the National Cancer Expert Reference Group (NCERG) and all state and territory governments.

Register today 

Keep reading

Nicotine vaping products for quitting smoking

Thursday 14 October 2021

The Quitline is already receiving calls from people seeking help to quit vaping.

Read more

Recognising and responding to emotional cues in cancer care

Tuesday 10 August 2021

Cancer Council's Responding to Emotions in Cancer course has been developed to support clinical staff to manage difficult conversations.

Read more

2021 Clinical Network Executive Committee

Thursday 25 March 2021

The Clinical Network Executive Committee welcomes a new Chair and Co-Chair and identifies priority areas for its work informing Cancer Council Victoria's policy and advocacy objectives.

Read more

Testing times: The challenge of direct-to-consumer cancer marker tests

Friday 5 February 2021

Self-administered cancer tests are marketed as a way for people to take control of their health, but they may actually be undermining trust in evidence-based testing and putting people at risk.

Read more